Latest News and Press Releases
Want to stay updated on the latest news?
-
Montréal, Québec, Sept. 06, 2017 (GLOBE NEWSWIRE) -- Clementia Pharmaceuticals Inc. (NASDAQ: CMTA), une société biopharmaceutique d’essais cliniques, a annoncé aujourd’hui la...
-
MONTREAL, Sept. 06, 2017 (GLOBE NEWSWIRE) -- Clementia Pharmaceuticals Inc. (NASDAQ:CMTA), a clinical stage biopharmaceutical company, today announced that Dr. Clarissa Desjardins, CEO of Clementia...
-
MONTREAL, Aug. 31, 2017 (GLOBE NEWSWIRE) -- Clementia Pharmaceuticals Inc. (NASDAQ:CMTA), a clinical stage biopharmaceutical company, today announced upcoming data presentations highlighting our...
-
MONTRÉAL, Aug. 31, 2017 (GLOBE NEWSWIRE) -- Clementia Pharmaceuticals Inc. (NASDAQ:CMTA), une société biopharmaceutique d’essais cliniques, a annoncé aujourd’hui la présentation de données...
-
MONTRÉAL, Aug. 21, 2017 (GLOBE NEWSWIRE) -- Clementia Pharmaceuticals Inc. (NASDAQ:CMTA) (la « Société » ou « Clementia »), une société biopharmaceutique au stade clinique, a annoncé...
-
MONTREAL, Aug. 21, 2017 (GLOBE NEWSWIRE) -- Clementia Pharmaceuticals Inc. (NASDAQ:CMTA) (the “Company” or “Clementia”), a clinical stage biopharmaceutical company, today announced that the...